-
Product Name
ATPIF1 antibody
- Documents
-
Description
ATPIF1 Rabbit Polyclonal antibody. Positive IF detected in HeLa cells. Positive IP detected in HeLa cells. Positive WB detected in HeLa cells. Observed molecular weight by Western-blot: 12 kDa
-
Tested applications
ELISA, WB, IP, IF
-
Species reactivity
Human, Mouse; other species not tested.
-
Alternative names
ATPase inhibitory factor 1 antibody; ATPI antibody; ATPIF1 antibody; ATPIP antibody; IF(1) antibody; IF1 antibody; Inhibitor of F(1)F(o) ATPase antibody
-
Isotype
Rabbit IgG
-
Preparation
This antibody was obtained by immunization of ATPIF1 recombinant protein (Accession Number: NM_016311). Purification method: Antigen affinity purified.
-
Clonality
Polyclonal
-
Formulation
PBS with 0.1% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:500-1:5000
IP: 1:200-1:2000
IF: 1:50-1:500
-
Validations
HeLa cells were subjected to SDS PAGE followed by western blot with Catalog No:108324(ATPIF1 antibody) at dilution of 1:500
IP Result of anti-ATPIF1 (IP:Catalog No:108324, 4ug; Detection:Catalog No:108324 1:500) with HeLa cells lysate 3440ug.
Immunofluorescent analysis of (10% Formaldehyde) fixed HeLa cells using Catalog No:108324(ATPIF1 Antibody) at dilution of 1:50 and Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L)
-
Background
The H(+)-ATP synthase is a reversible engine of mitochondria that synthesizes or hydrolyzes ATP upon changes in cell physiology. ATP synthase dysfunction is involved in the onset and progression of diverse human pathologies. ATPIF1 gene encodes mitochondrial ATPase Inhibitory Factor 1 (IF1), also named ATPI, ATPIP or IP. Endogenous IF1 limits ATP depletion when the mitochondrial membrane potential falls below a threshold and the ATP synthase starts hydrolyzing ATP to pump protons out of the mitochondrial matrix. Mitochondrial content of IF1 controls the activity of oxidative phosphorylation mediating the shift of cancer cells to an enhanced aerobic glycolysis, thus supporting an oncogenic role of IF1 in cancer.
-
References
- Ivanes F, Faccenda D, Gatliff J. The compound BTB06584 is an IF1 -dependent selective inhibitor of the mitochondrial F1 Fo-ATPase. British journal of pharmacology. 171(18):4193-206. 2014.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"